Population-based Screening Cohort Study Reveals No Association Between Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM), Multiple Myeloma (MM), and Alopecia
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Bilal A, Der Mesropian P, Lam F, Shaikh G
. Oligosecretory Myeloma With Amyloidosis and Alopecia. J Investig Med High Impact Case Rep. 2018; 6:2324709617752737.
PMC: 5788141.
DOI: 10.1177/2324709617752737.
View
2.
Nia B, Dhaliwal P, Rodney I, Lewin M
. A case of plasma cell dyscrasia presenting as nonscarring alopecia. JAAD Case Rep. 2021; 15:30-32.
PMC: 8349910.
DOI: 10.1016/j.jdcr.2021.05.041.
View
3.
Claveau J, Wetter D, Kumar S
. Cutaneous manifestations of monoclonal gammopathy. Blood Cancer J. 2022; 12(4):58.
PMC: 9001632.
DOI: 10.1038/s41408-022-00661-1.
View
4.
Rognvaldsson S, Love T, Thorsteinsdottir S, Reed E, Oskarsson J, Petursdottir I
. Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies. Blood Cancer J. 2021; 11(5):94.
PMC: 8128921.
DOI: 10.1038/s41408-021-00480-w.
View